Tavegil Antiallergic agent, tablets, 1 mg, 20 pcs

Round, flat white or off-white tablets with beveled edges.

On one side there is a risk tablet and an engraving OT".

Pharmaco-therapeutic group

N4 Pollinosis (hay fever, including allergic rhinoconjunctivitis)

Hives of various origins

Itching, itchy dermatoses

Acute and chronic eczema, contact dermatitis as adjuvant therapy

Drug allergy as adjuvant therapy

Insect bites.

Application during pregnancy and during breastfeeding

Fertility Clinical data on the effect of clemastine on fertility in men and women are lacking.

Available preclinical data have highlighted potential adverse effects on male fertility at doses higher than the clinical oral dose in humans.

Pregnancy There are no sufficient data on the use of clemastine in pregnant women.

The use of the drug is contraindicated in pregnant women.

Breastfeeding period Antihistamines can be excreted in breast milk and affect the baby.

Clemastine fumarate is contraindicated in nursing women.

Dosage form

Tablets 1 mg.

Primary packaging 5 or 10 tablets in a blister made of combined material (PVC / PVDC / Aluminum foil).

Secondary packaging 1, 2, 3 or 6 blisters with instructions for use in a cardboard box.

Shelf life

3 years.

Do not use after the expiration date.

Name ENG

TAVEGYL

Clinical and pharmacological group

Blocker of histamine H1 receptors.

Antiallergic drug

ATX code

Clemastine

Dosage

1mg

Structure

clemastine hydrofumarate 1.34 mg, which corresponds to the content of 1 mg clemastine.

Excipients: lactose monohydrate - 107.66 mg, corn starch - 10.8 mg, talc - 5 mg, povidone - 4 mg, magnesium stearate - 1.2 mg.

Indications

Hay fever (allergic rhinoconjunctivitis)

urticaria of various origins

itching, itchy dermatoses

acute and chronic eczema, contact dermatitis

drug allergy

insect bites and stings.

INN / Active ingredient

Clemastine

Contraindications

Hypersensitivity to clemastine or other ingredients of the drug, as well as to similar antihistamines, pregnancy, breastfeeding, taking monoamine oxidase (MAO) inhibitors, lower respiratory tract diseases (including bronchial asthma), porphyria, children under 6 years of age (for this dosage form), lactase deficiency, lactose intolerance, glucose-galactose malabsorption

elderly patients.

Storage conditions and periods

At a temperature not exceeding 30 ° C. Keep out of the reach of children.

Specifications

Category

Allergy

Scope of the medicinal product

General

Release form

Tablet

Manufacturer country

Italy

Package quantity, pcs

twenty

Scope of application

Allergology

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Tavegil

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

R06AA04 Clemastine

Dosage form

Pills

Dosage (volume) of the substance in the preparation

1 mg

Expiration date in days

1095

The target audience

Children

Package weight, g

twenty

Mode of application

:

For oral administration.

Do not exceed the recommended dose!

The drug is taken orally before meals with water.

Adults and children over 12 years old: 1 tablet (1 mg) in the morning and in the evening.

On the recommendation of a doctor, the daily dose can be up to 6 tablets.

The maximum single dose should not exceed 2 tablets at a time.

Children aged 6 to 12 years: 1/2 - 1 tablet in the morning and evening.

Pharmaco-therapeutic group

:

Antiallergic agent - H1-histamine receptor blocker

"